Log In
Print
BCIQ
Print
Print this Print this
 

BRACAnalysis

  Manage Alerts
Collapse Summary General Information
Company Myriad Genetics Inc.
DescriptionDiagnostic that detects BRCA1 and BRCA2 mutation
Molecular Target Not applicable
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsCompanion diagnostic for olaparib; Detect mutations in BRCA1 and BRCA2 genes; Diagnose risk of developing breast and ovarian cancers, predict risk of breast and ovarian cancer in families carrying the mutated gene, detect BRCA1 gene mutations in breast cancer, screen for risk of breast-ovarian cancer; Predict risk of breast and ovarian cancer in families carrying the mutated gene; Screen for risk of breast-ovarian cancer
Regulatory Designation
Partner Laboratory Corp. of America Holdings

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

5

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today